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INTRODUCTION
Endocarditis related to pacemaker lead infection is a rare,
but serious condition in permanent venous tracing. Staphy-
lococci are involved in the majority of these infections (1-4)
and Achromobacter xylosoxidans is very rare cause of organism.
Although some studies reported that medical extraction of
even large vegetation appeared to be safe (5), usually the infect-
ed endocardial system must be entirely removed and appro-
priate antibiotic therapy pursued for 6 weeks (1, 6).
CASE REPORT
A 35-yr-old patient visited our hospital due to a unremitting
high fever and chills for 10 days. He had undergone a patch
closure of the ventricular septal defect (VSD) 18 yr before.
One year later, a VVI pacemaker was implanted via the right
subclavian vein because of complete heart block. Nine years
after that, a new VVI pacemaker with another right ventricu-
lar electrode was inserted controlaterally and the old pacing
lead was abandoned. Several months before admission, he had
the scaling and root planning at local dental clinic. He did
not have any intravenous treatment history.
On admission, vital signs were blood pressure 120/75
mmHg, body temperature 39℃, and pulse rate 75/min.
Physical examination revealed systolic ejection murmur in the
left second intercostal area. The results of a complete blood
count were normocytic, normochromic anemia, and leuko-
cytosis (15,400/ L). An elevated erythrocyte sedimentation
rate (ESR) (135 mm/hr) and positive C-reactive protein (CRP)
(13.5 mg/dL) were demonstrated. Chest radiography revealed
a mild cardiomegaly without active lesions in the lung paren-
chyma. Blood cultures were positive for Achromobacter xylosoxi-
dans (colorless growth on MacConkey agar, oxidase positive,
indole negative, saccharolytic, motile, rod-shaped nonfermen-
ters analyzed by Vitec) 5 times. Susceptibility study showed
that the strain was susceptible to ceftazidime, piperacillin,
cefoperazone, imipenem, trimethoprim-sulfamethoxazole,
and was resistant to aminoglycosides. Trans-thoracic echocar-
diogram (TTE) (Fig. 1A) and trans-esophageal echocardio-
gram (TEE) (Fig. 1B) identified the pacemaker lead in the
right ventricle (RV) attaching hyperechoic materials and also
a fluttering round hyperechoic mass with a stalk in the RV
outflow tract (RVOT). No shunt flow was detected through
the previous patch closure site in TTE and TEE. The function
of pacemaker was normal on pacemaker analysis and 24-hr
Holter monitoring.
Despite sensitive antibiotics of ceftazidime and piperacillin
for 3 weeks, patient’s status was not stabilized. Therefore, the
patient underwent a cardiac surgery through median sternoto-
my under extracorporeal circulation. Intraoperatively, yellow-
brown friable materials attached to the older electrode (Fig.
2) and the septal wall of RVOT were confirmed. Removal
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Pacemaker Lead Endocarditis Caused by Achromobacter xylosoxidans
We report the case of a 35-yr-old patient who presented with high fever and chills.
He had undergone a patch closure of the ventricular septal defect 18 yr before.
One year later, a VVI pacemaker was implanted via the right subclavian vein
because of complete heart block. Nine years after that, a new VVI pacemaker with
another right ventricular electrode was inserted controlaterally and the old pacing
lead was abandoned. Trans-thoracic and trans-esophageal echocardiogram iden-
tified the pacemaker lead in the right ventricle (RV) attaching hyperechoic materi-
als and also a fluttering round hyperechoic mass with a stalk in the RV outflow
tract. Cultures in blood and pus from pacemaker lead grew Achromobacter xylosoxi-
dans. A diagnosis of pacemaker lead endocarditis due to Achromobacter xylosoxi-
dans was made. In this regards, the best treatment is an immediate removal of the
entire pacing system and antimicrobial therapy.
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of infected wires, infected Dacron patch, and vegetations in
the RVOT, and curretage of infected RV wall were performed.
Cultures for Achromobacter xylosoxidans were positive in the
pus attached to the pacemaker lead. With sensitive antibi-
otics treatment, the patient was doing well 6 weeks postop-
eratively without any signs for infection. Epicardial pacing
was maintained. There were no adverse changes in the nor-
malized CRP and ESR. Thus, a transvenous permanent pace-
maker implantation was performed after confirming the paten-
cy of the left subclavian vein with venography.
A follow-up echocardiogram 1 yr later demonstrated no
detectable vegetations. The patients has been doing well with-
out recurrence of infection for 2 yr.
DISCUSSION
Infection of the pacemaker pouch and lead may occur in
1% to 7% of patients with a permanent pacemaker (3). The
microorganism most responsible for a late pacemaker lead
infection is Staphylococcus epidermidis (4). Achromobacter xylosoxi-
dans is a nonfermentative Gram-negative bacilli. This organ-
ism is opportunistic and usually affects severely immuno-
compromised patients such as those with neutropenia and
those with a malignant or cardiovascular disease (7, 8). To
the best of our knowledge, however, the present case is unique
in that there has been no report such as ours. A case report
of aortic valve and VSD Dacron patch infective endocarditis
due to Achromobacter xylosoxidans 15 yr after a VSD patch clo-
sure appeared on Medline search (9). He did not have any
definite cause of pacemaker lead endocarditis. Several months
before admission, he had the scaling and root planning at
local dental clinic.
The diagnosis is difficult by using conventional imaging
methods such as transthoracic echocardiogram. TEE can facil-
itate the diagnosis of pacemaker lead endocarditis, however, it
is sometimes not diagnostic (10, 11). In our case, the hyper-
echoic materials clearly appeared in TTE and TEE.
Some studies reported successful treatment with the use of
antibiotics alone in patients with a pacemaker lead endocardi-
tis, however, the main management modality is cardiac surgery
(12). Patients are recommended to be treated with prolonged
antibiotic regimens before and after electrode removal (3). The
electrode removal can be achieved by surgery or traction. Per-
cutaneous traction is not simple and associated with compli-
cations, such as a tear of the tricuspid valve. Some patients
Fig. 1. (A) Transthoracic echocardiogram, apical four-chamber view. A pacemaker lead with attached hyperechoic materials is seen in
the right ventricle. (B) Transesophageal echocardiogram. A hyperechoic mass with a stalk is freely movable in the right ventricular out-
flow tract.
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Fig. 2. The removed electrode. It was destroyed and attached with
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need a new permanent pacemaker (3).
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